| # | Drug | Count |
|---|---|---|
| 0 | PEMBROLIZUMAB | 25 |
| 1 | NIVOLUMAB | 10 |
| 2 | IPILIMUMAB | 9 |
| 3 | CARBOPLATIN | 6 |
| 4 | PEMETREXED DISODIUM | 5 |
| 5 | AXITINIB | 4 |
| 6 | ASPIRIN | 3 |
| 7 | ASPIRIN 325 MG | 3 |
| 8 | ASPIRIN 81 MG | 3 |
| 9 | ASPIRIN TABLET 325MG | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NALDEMEDINE | 1 | 0.0011 |
| 1 | PEMBROLIZUMAB | 25 | 0.0007 |
| 2 | PEMETREXED DISODIUM | 5 | 0.0004 |
| 3 | AXITINIB | 4 | 0.0003 |
| 4 | IPILIMUMAB | 9 | 0.0003 |
| 5 | ICOSAPENT ETHYL | 1 | 0.0002 |
| 6 | METHIMAZOLE | 1 | 0.0002 |
| 7 | NIVOLUMAB | 10 | 0.0002 |
| 8 | APREPITANT | 2 | 0.0002 |
| 9 | LUBIPROSTONE | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 35 | 0.0003 |
| 1 | CTLA-4-directed Blocking Antibody [EPC] | 9 | 0.0003 |
| 2 | Thyroid Hormone Synthesis Inhibitor [EPC] | 1 | 0.0002 |
| 3 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 2 | 0.0001 |
| 4 | Chloride Channel Activator [EPC] | 1 | 0.0001 |
| 5 | Platinum-based Drug [EPC] | 6 | 0.0000 |
| 6 | Peroxisome Proliferator Receptor alpha Agonist [EPC] | 2 | 0.0000 |
| 7 | Kinase Inhibitor [EPC] | 4 | 0.0000 |
| 8 | Microtubule Inhibitor [EPC] | 1 | 0.0000 |
| 9 | l-Thyroxine [EPC] | 1 | 0.0000 |